Respiratory Health Diagnostic Seeks New Partner As RB Deal Aborted
Australia's ResApp has terminated a deal with RB to bring to market a smartphone app to identify different respiratory conditions. Previously, Sanofi and ResApp failed to agree a deal for the technology.
You may also be interested in...
Reckitt will work with former Sanofi partner ResApp to develop a consumer app which can diagnose common respiratory issues. The partnership represents RB's latest move into the digital space for its Health business.
Sanofi Consumer Healthcare is working with digital health firm ResApp to develop a mobile application which consumers can use to diagnose and manage respiratory illnesses. Such a tool has the potential to support novel Rx-to-OTC switch applications in future.
With around half the French population vitamin D deficient, a group of medical experts say mass supplementation is a low cost and low risk intervention which could save lives and curb the spread of COVID-19.